Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL)

CUSIP: 45783C101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.000001 par value per share
Shares outstanding
6,795,789
Total 13F shares
101,672,812
Share change
-17,606,637
Total reported value
$64,055,715
Put/Call ratio
24%
Price per share
$0.63
Number of holders
74
Value change
-$83,583,995
Number of buys
39
Number of sells
51

Security key

45783C101

Report period

Q4 2022

Institutions

74

Top holders

10

Top shareholders of TIL - Instil Bio, Inc. - Common Stock, $0.000001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Curative Ventures V LLC
13F
Company
559%
37,980,073
$183,824,000 30 Sep 2022
13F
FMR LLC
13F
Company
286%
19,454,035
$94,157,000 30 Sep 2022
13F
Vivo Capital, LLC
13F
Company
184%
12,486,787
$60,436,000 30 Sep 2022
13F
CPMG Inc
13F
Company
121%
8,218,467
$39,777,000 30 Sep 2022
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
113%
7,670,793
$37,127,000 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
75%
5,104,501
$24,705,000 30 Sep 2022
13F
BlackRock Finance, Inc.
13F
Company
68%
4,624,739
$22,383,000 30 Sep 2022
13F
Venrock Adviser, LLC
13F
Company
60%
4,105,779
$19,872,000 30 Sep 2022
13F
BAKER BROS. ADVISORS LP
13F
Company
57%
3,893,700
$18,846,000 30 Sep 2022
13F
ArrowMark Colorado Holdings LLC
13F
Company
35%
2,393,683
$11,585,000 30 Sep 2022
13F
Samsara BioCapital, LLC
13F
Company
26%
1,788,280
$8,655,000 30 Sep 2022
13F
MARSHALL WACE, LLP
13F
Company
24%
1,615,858
$7,821,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
18%
1,204,671
$5,830,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
16%
1,119,932
$5,420,000 30 Sep 2022
13F
Nicholas Investment Partners, LP
13F
Company
13%
897,386
$4,343,000 30 Sep 2022
13F
Fairmount Funds Management LLC
13F
Company
9.9%
673,905
$3,262,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
8.2%
554,885
$2,686,000 30 Sep 2022
13F
JPMORGAN CHASE & CO
13F
Company
7.3%
497,938
$2,410,000 30 Sep 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
6.9%
471,114
$2,281,000 30 Sep 2022
13F
Artal Group S.A.
13F
Company
6.6%
450,000
$2,178,000 30 Sep 2022
13F
Logos Global Management LP
13F
Company
4.9%
331,872
$1,606,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
4.2%
286,983
$1,389,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
3.9%
267,500
$1,294,000 30 Sep 2022
13F
Bank of New York Mellon Corp
13F
Company
3.6%
245,557
$1,189,000 30 Sep 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.5%
238,434
$1,154,000 30 Sep 2022
13F
Nuveen Asset Management, LLC
13F
Company
3.4%
231,980
$1,123,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
3.3%
227,076
$1,099,000 30 Sep 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
3%
203,580
$985,000 30 Sep 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
2.6%
176,155
$853,000 30 Sep 2022
13F
Vident Investment Advisory, LLC
13F
Company
1.9%
125,869
$609,000 30 Sep 2022
13F
RHUMBLINE ADVISERS
13F
Company
1.5%
104,592
$506,000 30 Sep 2022
13F
Long Focus Capital Management, LLC
13F
Company
1.5%
100,000
$484,000 30 Sep 2022
13F
QVT Financial LP
13F
Company
1.5%
98,644
$477,000 30 Sep 2022
13F
M&T BANK CORP
13F
Company
1.3%
90,740
$440,000 30 Sep 2022
13F
Parametrica Management Ltd
13F
Company
1.3%
88,263
$428,000 30 Sep 2022
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
1.3%
87,350
$423,000 30 Sep 2022
13F
ALPS ADVISORS INC
13F
Company
1%
70,827
$343,000 30 Sep 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.97%
66,232
$322,000 30 Sep 2022
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.87%
59,380
$287,000 30 Sep 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.76%
51,403
$249,000 30 Sep 2022
13F
Trexquant Investment LP
13F
Company
0.73%
49,839
$241,000 30 Sep 2022
13F
DEUTSCHE BANK AG\
13F
Company
0.7%
47,626
$231,000 30 Sep 2022
13F
MetLife Investment Management, LLC
13F
Company
0.64%
43,334
$209,737 30 Sep 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.63%
42,563
$206,000 30 Sep 2022
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.63%
42,489
$206,000 30 Sep 2022
13F
Graham Capital Management, L.P.
13F
Company
0.59%
39,894
$193,000 30 Sep 2022
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.49%
33,037
$160,000 30 Sep 2022
13F
Rockefeller Capital Management L.P.
13F
Company
0.46%
31,112
$150,000 30 Sep 2022
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.43%
29,524
$142,896 30 Sep 2022
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.41%
28,159
$136,290 30 Sep 2022
13F

Institutional Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q4 2022

As of 31 Dec 2022, Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 101,672,812 shares. The largest 10 holders included Curative Ventures V LLC, Vivo Capital, LLC, FMR LLC, CPMG Inc, BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Samsara BioCapital, LLC, MARSHALL WACE, LLP, and STATE STREET CORP. This page lists 74 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
87
Q4 2022 holders
74
Holder diff
-13
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .